Marion Gruber
Biographic Data
| ID | 9797037 |
|---|---|
| NAME | Marion Gruber |
| GIVEN NAMES | Marion |
| FAMILY NAME | Gruber |
| SIGNATURE | GRUBER M |
| AFFILIATIONS | Center for Biologics Evaluation and Research |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Evolving pharmacovigilance requirements with novel vaccines and vaccine components
This paper explores the pipeline of new and upcoming vaccines as it relates to monitoring their safety. Compared with most currently available vaccines, that are constituted of live attenuated organisms or inactive products, future vaccines will also be based on new technologies. Several products that include such technologies are either already licensed or at an advanced stage of clinical development. Those include viral vectors, genetically att…
No prominent works on this page.
Evolving pharmacovigilance requirements with novel vaccines and vaccine components
This paper explores the pipeline of new and upcoming vaccines as it relates to monitoring their safety. Compared with most currently available vaccines, that are constituted of live attenuated organisms or inactive products, future vaccines will also be based on new technologies. Several products that include such technologies are either already licensed or at an advanced stage of clinical development. Those include viral vectors, genetically att…
Adverse effect (1 work) · Medicine (1 work) · Pharmacology (1 work) · Pharmacovigilance (1 work) · Pharmacovigilance and Adverse Drug Reactions (1 work) · SARS-CoV-2 and COVID-19 Research (1 work) · Vaccine Coverage and Hesitancy (1 work) · Virology (1 work)